Portfolio
Payments companies reported to CMS as associated with Portfolio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Portfolio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Portfolio
These are the largest totals companies reported as associated with Portfolio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Dalton | Austin, TX | Foot and Ankle Surgery | $579,898.52 |
| Mark Myerson | Baltimore, MD | Orthopaedic Surgery | $536,284.92 |
| Byron Hutchinson | Burien, WA | Podiatrist | $497,631.86 |
| Jeffrey Christensen | Everett, WA | Foot & Ankle Surgery | $378,373.11 |
| Michael Houghton | Fort Collins, CO | Foot and Ankle Surgery | $315,038.99 |
| Paul Fortin | Royal Oak, MI | Orthopaedic Surgery | $286,316.21 |
| Thomas Sangiovanni | Coral Gables, FL | Foot and Ankle Surgery | $266,156.44 |
| Mark Prissel | Worthington, OH | Foot & Ankle Surgery | $217,894.11 |
| Cesar De Cesar Netto | Iowa City, IA | Orthopaedic Surgery | $206,399.03 |
| Michael Brage | Seattle, WA | Orthopaedic Surgery | $194,000.99 |
Prescribed Portfolio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.